Algeta ASA
oslo : ALGETA

August 19, 2013 01:09 ET

Algeta schedules first half and second quarter 2013 results presentation, webcast and conference call

OSLO, NORWAY--(Marketwired - Aug 19, 2013) - Algeta ASA (OSE: ALGETA), a company focused on the development of novel targeted cancer therapeutics, will announce its first half and second quarter 2013 results on Wednesday, 28 August 2013. A presentation by members of Algeta's executive management team to investors, analysts and the press will take place in Oslo at 10:00 CET.

The presentation will also be webcast live and can be accessed through www.algeta.com where questions can also be submitted during the presentation.

The presentation will take place at 10:00 CET at:

KS-Agenda Møtesenter

Haakon VIIs gate 9

0161 Oslo

Norway.

Algeta will also host an international conference call at 14:30 CET/08:30 Eastern Time (US) (details below).

To participate in the conference call, please dial the appropriate number below five minutes prior to the call:

US: +1 877 423 0830

UK: +44 20 7153 9154

Norway: +47 21 06 61 13

Sweden: +46 8-506 443 86

Denmark: +45 32 71 42 62

Switzerland: +41 44 580 65 22

Participant pin code: 197187#

To access the replay, please dial:

US: +1 877 679 2989

UK: +44 203 364 5200

Norway: +47 23 50 02 03

Sweden: +46 8-505 564 73

Conference reference: 348084#

A replay of the conference call will also be available at www.algeta.com.

The results report and the presentation will be available at www.algeta.com in the Investors section from 07:00 CET.

About Algeta

Algeta is a company focused on developing novel targeted therapies for patients with cancer based on its alpha-pharmaceutical platform. The Company is headquartered in Oslo, Norway, and has a US subsidiary, Algeta US, LLC, based in Cambridge, MA performing commercial marketing operations in the US. Algeta is listed on the Oslo Stock Exchange (Ticker: ALGETA). For more information please visit www.algeta.com.

Press release:

http://hugin.info/134655/R/1723290/574283.pdf

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Algeta ASA via Thomson Reuters ONE

[HUG#1723290]

Contact Information

  • For further information, please contact:

    Mike Booth / Renate Birkeli
    Communications & Corporate Affairs
    +47 23 00 67 32
    Email Contact

    Media enquiries:
    Mark Swallow
    Citigate Dewe Rogerson
    +44 207 638 9571
    Email Contact

    Knut Ekern
    Gambit Hill & Knowlton
    +47 22 04 82 00
    Email Contact

    Kari Watson
    MacDougall Biomedical Communications
    +1 781 235 3060
    Email Contact
    Investor enquiries:

    Tricia Swanson
    The Trout Group
    +1 646 378 2953
    Email Contact